Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
デスカルボエトキシロラタジンを用いるアレルギー性鼻炎および他の疾患の治療のための方法および組成物
Document Type and Number:
Japanese Patent JP4237822
Kind Code:
B2
Abstract:
A composition comprising DCL, or a pharmaceutically acceptable salt thereof, for treating allergic rhinitis, allergic asthma, retinopathy or other small vessel diseases associated with diabetes mellitus, urticaria, or symptomatic dermographism in a human, while avoiding the concomitant liability of adverse side effects associated with the administration of non-sedating antihistamines, by administering to said human a therapeutically effective amount of DCL or pharmaceutically acceptable salt thereof.

Inventors:
Aberg, AK Gunner
McCullough, John Earl.
Smith, Emile Earl.
Application Number:
JP52100296A
Publication Date:
March 11, 2009
Filing Date:
December 11, 1995
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Sepra Core, Incorporated
International Classes:
A61K31/445; C07D401/04; A61K31/4427; A61K31/451; A61K31/4545; A61K45/06; A61P3/08; A61P3/10; A61P9/10; A61P11/06; A61P17/00; A61P25/04; A61P27/00; A61P27/02; A61P27/14; A61P27/16; A61P29/00; A61P31/12; A61P31/16; A61P37/08
Domestic Patent References:
JP61501205A
JP61289087A
JP2503909A
Foreign References:
WO1994003170A1
US5019591
Other References:
Jorg Kleine-Tebbe, J. Allergy Clin. Immunol., 1994年 2月, Vol.93, No.2, Pages 494-500
Attorney, Agent or Firm:
Yusuke Hiraki
Ishii Teiji
Setuko Mayama